SAE Media Group’s 7th Annual Conference
Pre-Filled Syringes West Coast
June 12 - 13, 2023 | San Diego, CA, USA
SAE Media Group’s 7th Annual Pre-Filled Syringes West Coast Conference will be back for 2023 in San Diego to bring together the device developers, innovative biotech and big pharma. This year’s conference will explore the exciting advances in the combination product drug delivery space and a future outlook exploring how pharma, device developers and regulators can work together to encourage innovation.

With the injectable drug delivery industry rapidly advancing year-to-year, administration using pre-filled syringes, auto-injectors, and pen-injectors are increasingly common. Innovations in device technology, such as connected devices are leading the way in device design in addition to injectable delivery devices for novel and large volume drugs. With the need for self-administration growing, there is an enhanced demand for on-body injectors and digitalised health as well as patient centricity. We are beginning to see environmental sustainability being incorporated into aspects of device lifecycle from design to manufacturing and the use of the device. This year’s conference looks to address these hot topics through case studies and industry insights.

As part of SAE’s leading injectable drug delivery conferences this is a must attend event; not only will the conference bring you key insights to enhance your drug device portfolio, but it will also give you the opportunity to network with key industry players. We hope to welcome you in June 2023!

Watch now: Speaker interview with Nicholas Mandala, Vice President for Medical Devices and Combination Products Technology, Pfizer

  • Engage with industry representatives about the latest technologies and advances within the injectable device market and directions to take to advance your device portfolio
  • Gain insight into new technologies for wearable injectors he delivery of novel and large volume drugs
  • Understand the latest regulatory requirements and guidance to ensure your combination products are compliant such as meeting essential performance requirements
  • Delve into aspects of primary packaging such as material components to consider during device design to ensure drug stability and safety
  • Explore how digital technologies such as companion apps are being incorporated into drug delivery devices to improve user-centricity



Directors, Heads of Departments and Managers for the following areas:

  • Device Development
  • Device Engineering
  • Combination Product Development
  • Drug Delivery Devices
  • Primary Packaging Development
  • Digital Health
  • Large Volume Drug Delivery
  • Novel Drug Product Formulation
  • Regulatory Affairs

AbbVie; Amgen; AnaptysBio; AstraZeneca; BCM Group LLC; BD; Bexson Biomedical; Biogen; Biomarin Pharmaceutical; BioMarin Pharmaceutical, Inc.; BioPhorum; Boston Analytical; Cambridge Design Partnership; Corning; Credence MedSystems; Datwyler Pharma Packaging USA; Elcam E3d ACAL Ltd; Genentech; Halozyme Therapeutics; Haselmeier; Heron Therapeutics ; Immunovant; Ionis Pharmaceuticals; Janssen Pharmaceuticals; Johnson & Johnson; Kymanox; MACH32 Inc; Medical Design Briefs; My Green Lab ; NEMERA; Nemera services; Noble International; Noble International Inc.; Owen Mumford; PHC Corporation; PHC Corporation of North America; Raumedic; Raumedic AG; Regeneron Pharmaceuticals; Sagentia Ltd; Sanofi US; Scherdel Medtec North America; Schott North America; Semigator GmbH; SureMed Technologies; Takeda Pharmaceuticals; Terumo Pharmaceutical Solutions; Teva Pharmaceuticals; UserWise; Zeon Specialty Materials ; ZwickRoell;

Conference programme

8:00 Registration & Coffee

9:00 Co-Chair Opening Remarks

Scott Nunn

Scott Nunn, Director, Device Development, Gilead Sciences, Inc
View Bio

Natalie Abts

Natalie Abts, Head of Human Factors Engineering, Genentech
View Bio

9:10 New Alternatives for Subcutaneous Drug Delivery and Human Factors Implications

Tina Rees

Tina Rees, Associate Director, Human Factors, Regeneron Pharmaceuticals
View Bio

  • Reviewing the current landscape of emerging technologies to support parenteral drug delivery
  • Assessing industry challenges in the emerging technologies space and potential ways to overcome these
  • Assessing the impact of new technologies on human factors testing
  • Special considerations and developing a successful human factors strategy
  • 9:40 Leading Pharmaceutical Manufacturer Launches RFID-Embedded prefilled Syringes to Enhance Patient Safety

    Gary Burns

    Gary Burns, Founder at eAgile, eAgile a CCL Healthcare company
    View Bio

  • RFID Embedded Pre-Filled Syringes and the Prevention of medication errors
  • Enhancing Patient Safety and Clinician Efficiency
  • Key Step toward the Autonomous Hospital Pharmacy
  • RFID Value Creation Across the Continuum of Care
  • Filling a Critical Role in Hospital Inventory Management
  • End to End Supply Chain Visibility and Chain of Custody
  • And much more!
  • 10:10 Successfully Implementing Effective Post Market Surveillance Processes for Injectable Devices

    Khaudeja Bano

    Khaudeja Bano, Vice President, Combination Product Quality, Amgen
    View Bio

  • Discussion of key PMS and medical device vigilance concepts and requirements
  • Guidance on compiling PMS reports and periodic safety update reports for combination products
  • Case studies on effective approaches for efficient report maintaining for injection devices
  • Insight into utilising surveillance feedback to identify areas of continuous improvement
  • 10:40 Morning Coffee

    11:10 Collaboration to Meet Market Demand for Dual Chamber Drug/Device Combination Products: Combining Innovation in Drug Delivery Devices and Pharmaceutical Contract Manufacturing

  • The need for various Dual Chamber solutions to meet ‘Ready-to-Use’ requirements
  • Trends in Dual Chamber applications: Reconstitution and Sequential injection
  • Credence MedSystems and Bryllan: The collaboration provides product developers an end-to-end partnership for syringe innovation and flexible fill finish capability
  • Accelerated scaling approaches to meet increased demand for clinical and commercial capacity for dual chamber syringe technologies
  • Doug  Bryans

    Doug Bryans, President and CEO, Bryllan LLC
    View Bio

    John Merhige

    John Merhige, CEO, Credence MedSystems
    View Bio

    11:40 ISO Standards for Needle Injection Systems and Successful Applications

    Porsche Bennett

    Porsche Bennett, Acting Team Lead, General Hospital Team, Food and Drug Administration
    View Bio

  • Assessing the need for clarified or updated guidance
  • Reviewing international standards such as ISO 23908, ISO 11040 and ISO 11608
  • Insight into successfully applying these standards when developing prefilled syringes with needle safety devices and autoinjectors


  • 12:10 Taking a Platform Approach for Combination Product and Injection Device Development

    Nicholas Mandala

    Nicholas Mandala, VP Medical Devices & Combination Products Technology, Pfizer
    View Bio

  • What delivery systems and devices are suitable for platforms and tailoring for a range of delivery volumes
  • How can platforms be used to maximise product success: a case study
  • What is the impact of regulations: looking at ISO11608 and updates
  • Strategies for advancing and implementing a platform approach
  • 12:40 Networking Lunch

    13:40 Delivering Large Volume at Home with a Sustainable Wearable Injector Platform

    Cecile Gross

    Cecile Gross, Category Manager Parenteral, Nemera
    View Bio

  • Challenges of large volume drugs for the industry
  • Addressing chronic diseases with large volume drugs
  • Challenges for delivering large volume injections at home
  • Drivers for designing a sustainable platform to address all these challenges
  • Necessity of a patient-centric approach
  • 14:10 Device Development Strategies for Long Acting Injectables

    Son Tran

    Son Tran, Associate Director, Device Engineering, Gilead Sciences
    View Bio

  • Review of how HIV treatment has evolved over time
  • Key considerations for development of long-acting formulations
  • Challenges to establishing effective delivery devices for long acting injectables
  • 14:40 A Glass Alternative: ZEONEX® and ZEONOR® Cyclo Olefin Polymer (COP) for Pre-Filled syringes

    Larry Atupem

    Larry Atupem, Business Development Manager, Zeon Specialty Materials
    View Bio

  • Key Benefits of COP for Medical Devices
  • Case Study on Delamination: COP Syringe vs Glass Syringe
  • Case Study on Protein Adsorption/Aggregation and its effect on Immunogenicity
  • 15:10 Afternoon tea

    15:40 Making a Material Choice: Polymer vs Glass

    Yusuf Oni

    Yusuf Oni, Associate Director, Bristol Myers Squibb
    View Bio

  • Assessing the current landscape of primary packaging material for pre-filled syringes and injectable drug delivery devices
  • Comparison of glass and polymer materials
  • Exploring the challenges for drug stability and safety: permeation behaviour, difference regarding their break resistance and siliconization
  • What should be considered when selecting polymer vials?
  • 16:10 Latest data for multilayer plastic vial

    Shota Arakawa

    Shota Arakawa, Researcher , Mitsubishi Gas Chemical Company, Inc
    View Bio

  • Multilayer plastic vial
  • Oxygen barrier for stabilization of biologics
  • Ultraviolet light barrier for stabilization of biologics
  • Extremely low inorganic extractables & pH stability
  • Low risk of breakage at extremely low temperature

  • 16:40 Assessment of the Impact of X-ray Screening on Product Quality for Biotherapeutic Products

    Aslin M. Rodriguez Nassif

    Aslin M. Rodriguez Nassif, Senior Scientist, Pfizer, Inc.
    View Bio

  • Evaluation of the risk of exposure of biological products to X-ray radiation during transportation
  • Evaluation of the impact of potential X-ray exposure to different biotherapeutic modalities
  • Quality Attributes assessment after X-ray radiation
  • 17:10 Co-Chair Closing Remarks and Close of Day One

    Scott Nunn

    Scott Nunn, Director, Device Development, Gilead Sciences, Inc
    View Bio

    Natalie Abts

    Natalie Abts, Head of Human Factors Engineering, Genentech
    View Bio

    8:30 Registration & Coffee

    9:00 Co-Chair Opening Remarks

    Scott Nunn

    Scott Nunn, Director, Device Development, Gilead Sciences, Inc
    View Bio

    Natalie Abts

    Natalie Abts, Head of Human Factors Engineering, Genentech
    View Bio

    9:10 Successful Digital Integration of Medical Devices and Life Cycle Management

    David Morra

    David Morra, Director, Devices and Digital Health, Merck, Sharpe, & Dohme
    View Bio

  • Reviewing developments in connected combination products over the past year and looking forward: How to capture novel opportunities in digital health
  • Optimising human-centred design and strategies for producing devices tailored to improve adherence
  • Regulatory considerations for the integration of digital components and ensuring compliance
  • What is the future for digital systems and increasing acceptance?
  • 9:40 Using Patient Centric Design to Develop a Connected Digital Device Solution

    Daniel Branco

    Daniel Branco, Board Member, Medicinia
    View Bio

  • Optimising digital strategies to deliver successful smart devices and connected platforms
  • Key patient and user considerations for the design of digital devices and connected platforms
  • Addressing the challenges in development and review of connected combination products and other digital health products
  • Outlook on the future of connectivity and wearable devices: how can more connected combination products be approved?
  • 10:10 Meaningfully CONNECTING with Patients for Home Infusion Therapy!

    Ravi Kaushik

    Ravi Kaushik, Vice President, Patient Integrated Care Innovation Platform, Takeda Pharmaceuticals
    View Bio

  • As patients manage their home infusion therapy with combination devices– we need to strive to make digital companion apps and voice enabled (hands free) – become part of their daily routine
  • We can share the progress we are making on these efforts and learnings we have
  • 10:40 Morning Coffee

    11:10 Sustainability Implications in Electro-Mechanical Devices

    Karthik Vaideeswaran

    Karthik Vaideeswaran, Associate Vice President, Eli Lilly And Company
    View Bio

  • Discussing the shadow effect of incorporating connectivity into injection devices
  • Assessing electro-mechanical device production to final use and end of life, and areas to be reviewed
  • Examining secondary packaging and opportunities for reducing plastic use
  • How can the pharma industry and other stakeholders collaborate to overcome challenges and advance sustainability?
  • 11:40 Panel Discussion: Promise, Challenges and Considerations for Developing Smart Injectables for Clinical and Commerical Operations

  • How can we generate value from connected devices? Examining what additional benefits connectivity brings
  • How can we utilise connectivity to decentralise healthcare, disease management and more?
  • Does the patient really benefit from connected health or is it a push by payers and device manufacturers? Identifying the connected features that provide beneficial user guidance and patient adherence
  • How does connected devices and digital health fi t to user needs?
  • Amin Sedighiamiri

    Amin Sedighiamiri, Associate Director Device Development, AstraZeneca
    View Bio

    Ravi Kaushik

    Ravi Kaushik, Vice President, Patient Integrated Care Innovation Platform, Takeda Pharmaceuticals
    View Bio

    Karthik Vaideeswaran

    Karthik Vaideeswaran, Associate Vice President, Eli Lilly And Company
    View Bio

    David Morra

    David Morra, Director, Devices and Digital Health, Merck, Sharpe, & Dohme
    View Bio

    12:20 Networking Lunch

    13:20 Formulating Design Inputs to Develop the Right Device for the Right Patients

    Alex Baker

    Alex Baker, Senior Engineer II, Biogen
    View Bio

  • Synthesizing user research and task analyses to formulate validation-ready user needs
  • Crafting Use Cases to define features, align stakeholders, and drive lower-level requirements
  • Balancing must-have and nice-to-have requirements and planning for future generations of product
  • Choosing the right device platform for a specific drug and patient population
  • 13:50 “Go Digital” The Solution to a Problem or a Problem Without a Solution?

    Frank Leipold

    Frank Leipold, VP Product Management, Haselmeier GmbH
    View Bio

  • Solution development based on patient needs versus utilization rates in the real world
  • Experiences and challenges, developing connected solutions for patients performing self-injection at home
  • New connected devices and solutions
  • Learning from other industries
  • The importance of partnerships
  • 14:20 Incorporating Patient Centricity into Product Design

    Angela Muriset

    Angela Muriset, Director, Human Factors - Combination Product Development, AbbVie
    View Bio

  • Carrying out human factors and usability studies to understand patient needs and preference
  • Strategies for successfully implementing patient centric design into device development
  • Assessing the impact of patient centricity on dosage form design and lifecycle improvements
  • Reviewing user needs, technical requirements, commercial requirements, and development requirements for key decision criteria
  • 14:50 Afternoon Tea

    15:20 A Meta-Analysis of Shipping Simulation of Elastomeric Plungers for Syringe and Cartridge Barrels

    Gabrielle Gehron

    Gabrielle Gehron, Scientific Support Manager, Datwyler
    View Bio

  • Evaluation of shipping simulations on plungers in various conditions
  • Variety of factors can affect success during shipping simulations, including:
  • Component dimensions
  • Storage conditions
  • Elevation
  • Number of pressure cycles
  • Glean important lessons about performance testing through meta-analysis


  • 15:50 Adaptable Human Factors Studies

    Natalie Abts

    Natalie Abts, Head of Human Factors Engineering, Genentech
    View Bio

  • Choosing the type of human factors assessment to meet your development goals
  • Novel methods for early stage studies
  • Combining efforts across projects to streamline development
  • Adapting study designs to address the unexpected
  • 16:20 Insights & Implications from U.S. FDA-UserWise Training Decay

    Shrikar Tatapudi

    Shrikar Tatapudi, Human Factors Engineer, UserWise
    View Bio

  • An overview of Training Decay and why it matters
  • What does the FDA say about Training Decay
  • Insights and revelations from UserWise’s FDA-backed training decay research study
  • How could our findings affect future regulatory policy
  • 16:50 Co-Chair Closing Remarks and Close of Day Two

    Natalie Abts

    Natalie Abts, Head of Human Factors Engineering, Genentech
    View Bio

    Scott Nunn

    Scott Nunn, Director, Device Development, Gilead Sciences, Inc
    View Bio


    Senior Engineer II
    Associate Director Device Development
    Director, Human Factors - Combination Product Development
    Senior Scientist
    Pfizer, Inc.
    Category Manager Parenteral
    Board Member
    Board Member
    Director, Devices and Digital Health
    Merck, Sharpe, & Dohme
    President and CEO
    Bryllan LLC
    VP Product Management
    Haselmeier GmbH
    Scientific Support Manager
    Founder at eAgile
    eAgile a CCL Healthcare company
    Credence MedSystems
    Associate Vice President
    Eli Lilly And Company
    Vice President, Combination Product Quality
    Business Development Manager
    Zeon Specialty Materials
    Head of Human Factors Engineering
    VP Medical Devices & Combination Products Technology
    Acting Team Lead, General Hospital Team
    Food and Drug Administration
    Vice President, Patient Integrated Care Innovation Platform
    Takeda Pharmaceuticals
    Director, Device Development
    Gilead Sciences, Inc
    Mitsubishi Gas Chemical Company, Inc
    Human Factors Engineer
    Associate Director, Device Engineering
    Gilead Sciences
    Credence MedSystems
    Associate Director, Human Factors
    Regeneron Pharmaceuticals
    Associate Director
    Bristol Myers Squibb



    Official Media Partner


    Horton Grand Hotel

    San Diego, USA

    A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing the SMi Group. SMi Group books all hotel rooms directly. If you are approached by a third party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.

    Preliminary Attendee List


    Past-Attendee List


    Speaker Interview: Nicholas Mandala from Pfizer


    Speaker Interview: Alex Baker, Senior Engineer II, Biogen



    CCL Healthcare


    eAgile a CCL Healthcare company, is an innovative and industry leading IoT and RFID brand protection solutions has led to the continual expansion of its facilities, capabilities, and products. Today, eAgile is governed by ISO 9001:2015 certified quality management system and operates out of a vertically integrated facility complete with design, manufacturing, testing and demonstration centers. eAgile distributes standard or customized Security Printing, IoT and RFID products in UHF, HF, NFC, LF and Dual frequencies across a wide variety of form factors including custom hardware and software solutions. eAgile’s commitment to innovation, quality and providing customer focused solutions drives every aspect of the business from tag selection to the design and integration of complete RFID infrastructures.



    Datwyler provides high-quality, system-critical elastomer components and has a leading position in the global healthcare market. Within the healthcare solutions business area, Datwyler develops, designs, and manufactures solutions for injectable packaging and drug delivery systems to facilitate customers to create a safer medical environment of tomorrow. Looking back onto more than 100 years of history, Datwyler is a reliable partner, now and in the future!



    o Haselmeier, the drug delivery device business of medmix, designs, develops and manufactures advanced drug delivery systems such as pen injection systems and autoinjectors. Patient comfort and customers’ needs are always at the heart of the company’s practices. With its broad portfolio of technologies and services, Haselmeier delivers user-friendly injection systems that enable patients to self-administer their medication reliably and accurately. Haselmeier is known for its excellent and long-standing track record in providing these innovative drug delivery devices based on its proprietary IP business model. The company collaborates closely with its customers in the pharmaceutical and biopharmaceutical industries. Medmix, with its precision injection molding capabilities and expertise in liquid micro-dosing plus financial strength and global footprint, helps Haselmeier accelerate innovation in healthcare. With more than 100 years of expertise in the development and manufacture of drug delivery devices, our global footprint, nearly 250 distinguished and motivated experts, more than 200 patents granted, and numerous patents pending, Haselmeier remains committed to developing innovative solutions that support our customers and help improve the health of millions of people worldwide.

    Mitsubishi Gas Chemical


    Mitsubishi Gas Chemical is a leading company in the field of oxygen barrier and absorbing technologies. Based on these technologies and experiences, we have successfully developed multilayer plastic vial and syringe having excellent oxygen, ultra violet and water vapor barrier. The products make it possible to replace glass with plastic for injectable drugs.



    As a world-leading drug delivery device solutions provider, our purpose of putting patients first enables us to design and manufacture devices that maximize treatment efficacy. We are a holistic partner and help our customers succeed in the sprint to market of their combination products. From early device strategy to state-of-the-art manufacturing, we’re committed to the highest quality standards. Agile and open-minded, we work with our customers as colleagues. Together, we go the extra mile to fulfill our mission.



    o ZEON’s Zeonex® and Zeonor® cyclo olefin polymer (COP) allow for advanced, break-resistant syringes, vials and lyophilization containers for protein-based biopharmaceuticals, high viscosity drugs, and contrast media. They also offer high purity, “glass-like” transparency, sterilization, low water absorption, and superior moldability, as well as overcome protein adsorption and ph shift concerns. Please visit our booth and discover why COP is an excellent choice for drug storage and pre filled syringes.


    Boston Analytical


    Boston Analytical is a cGMP compliant, FDA/DEA registered, ISO/IEC-17025:2005 certified analytical laboratory located in Salem, NH. Boston Analytical provides testing services to Pharmaceutical, Biopharmaceutical and Medical Device companies worldwide including Analytical Testing and Method Development, Microbiological Testing and Environmental Monitoring Services, Biologics, Stability Testing & ICH-compliant Storage, Nitrosamines Testing and Extractables & Leachables Studies.

    Credence MedSystems


    Credence MedSystems is an innovator in injectable drug delivery devices. Credence’s philosophy of Innovation Without Change results in products that impress and protect end-users while preserving pharma’s existing processes, sourcing strategies and preferred primary package components. The Companion® family of syringe systems includes proprietary needle-retraction technology, reuse prevention and other critical safety and usability features in Staked and Luer needle formats. The Dual Chamber platform offers single-step mixing and injection for drugs requiring reconstitution at the time of delivery. Additional products such as metered dose devices, multi-length staked needles and other novel devices address the needs of specific therapeutic markets.



    Exela Pharma Sciences, established in 2005 is a US based specialty pharmaceutical company located one hour west of Charlotte Douglas International Airport in Lenoir, North Carolina. Exela has two distinct and separate business units, a Finished Drug Products organization, manufacturing proprietary and generic sterile injectable products and a Contract Development and Manufacturing Organization (CDMO). Both businesses leverage significant cGMP sterile injectable manufacturing capabilities with capacity in liquid vials, lyophilized vials, pre-filled syringes, and IV bags. Exela has a proven track record of program execution under intense time pressures with exceptional service.

    The CDMO business is fully capable of meeting the manufacturing of pharmaceutical and biotech industry needs. Exela offers end to end contract manufacturing capabilities, from analytical development to large scale cGMP manufacturing, along with automated inspections, labeling and packaging services. Exela can also provide a dedicated team to address your warehousing, storage, and global distribution needs. Exela has the capacity for commercial supply in the tens of millions of units.

    For more information, or to receive a quote on our CDMO services, please contact Matt Delaney, VP Business Development for Exela at 512-922-2839, or by email at: gdelaney@exela.us.



    Kymanox is a life science professional services organization that offers engineering, scientific, project management, quality, and regulatory support to companies exclusively in the biotechnology, pharmaceutical, medical device, and combination product industries. With its diverse team of experts, Kymanox helps clients navigate commercialization challenges that arise throughout a product’s life cycle – from early development to post-market – with optimized safety, quality, efficacy, and accessibility. Kymanox was founded in 2004 and is headquartered in Morrisville, North Carolina USA. For more information, please visit www.kymanox.com.

    Owen Mumford


    Owen Mumford Pharmaceutical Services is a specialist in the design, development and manufacture of injectable drug delivery systems for the pharmaceutical, biotech & generics industries. These include single dose and multidose reusable and disposable auto-injectors, pens and syringes for subcutaneous and intramuscular administration. Our innovative products are designed to meet both the need of our pharmaceutical partners and their patients by facilitating ease of use and improving safety and patient compliance. Our devices are also designed with aim of reducing complexity and risk for the pharmaceutical & biotech industry in the development of their combination products.

    For more information please visit https://www.ompharmaservices.com/

    R+D Custom Automation


    R+D Custom Automation, a member of the Krones Group, has been a full-service automation & robotics system integrator serving the Life Sciences Industry exclusively for over 45 years. As a specialty equipment manufacturer R+D has gained prominence by integrating proven technologies into custom & platform-based solutions, solving the most complex production challenges for manufacturers in this space, including Medtech, Biotech and Pharmaceutical companies. Our custom offering covers a wide bandwidth of processes, including Assembly, Filling, Testing, Bag Making/Forming, Mold-Side Automation, Labeling, Kitting, Tray Handling, Pack-Out & Sealing, among others. Our filling expertise extends beyond the typical, bringing to the marketplace solution platforms for your low, medium, and high-volume requirements. R+D goes beyond providing just the automation, and that starts with our Process Development Segment. Through early partnership, we are with you from the very beginning of your process development, providing prototype & proof of concept solutions through every maturing production step along the way, into semi-auto, moderate and high-volume needs. From our humble beginnings in 1977 to our present-day state of the art facility in southern Wisconsin, R+D has become a premiere provider of automation equipment for the most recognized Life Sciences companies in the world.



    Together with its customers, the medical technology company is breaking new ground to improve the diagnosis and treatment of diseases. In doing so, Raumedic focuses on polymer-based solutions for medical and pharmaceutical applications, as well as on products for intensive care. Raumedic has a global presence and a headcount of approximately 1,000. In its core markets of Europe and North America, the company manufactures using its own clean room production facilities.

    SCHERDEL Medtec


    At SCHERDEL Medtec, we don’t just provide solutions, we provide care. Making components for the medical industry offers the unique privilege to our employees and the community.

    We’re proud to provide crucial, essential medical components to the people who need them. Scherdel employees understand that we manufacture more than just springs, we manufacture pieces of hope and health to individuals in need. At SCHERDEL Medtec, we believe that healthcare consists of two equal parts health and care.,

    The focus of our expertise is in the drug delivery device market sector. We supply 100’s of millions of springs and precision stampings for peninjectors, autoinjectors, syringe needle safety systems and other drug delivery devices. In addition to manufacturing these essential components, Scherdel also offers world class product development tools and expertise in numerical simulation and best in class engineering software tools.

    SCHERDEL Medtec, is part of the SCHERDEL Group. With about 5,800 employees at 32 locations world wide, the SCHERDEL Group is a family-owned, leading company in the field of metal-forming with core competence in the production of engineering springs, stamping parts and assemblies for the pharmaceutical market as well as of vehicle components.



    At teamtechnik, we have been living automation since 1976. As part of the Dürr Group, we are specialists in assembly and functional test systems. Globally, with more than 1,100 Employees, teamtechnik develops sophisticated production systems for high-tech products in the fields of e-mobility, medical technology and new energy. Our slogan… WE LIVE AUTOMATION.

    Our customers have to manufacture sophisticated injection products in large quantities. This requires highly accurate assembly and functional test processes. teamtechnik has developed a unique expertise in this area and provides reliable assembly solutions for pre-assembly, final assembly and function testing - the complete production chain from a single source.

    Media Partners

    On Drug Delivery

    Official Media Partner

    ONdrugDelivery provides 30,000 readers throughout global pharma/biopharma, with the latest, most pertinent industry information and intelligence about the drug delivery-related ideas, technologies, services and products the sector is developing. Established in 2004, and trusted throughout the industry for its high quality contributions from leading drug delivery experts, ONdrugDelivery is a must for pharma / biotech industry professionals who need to know what’s going on in drug delivery. Subscribe online today to the print or free digital edition: www.ondrugdelivery.com/subscribe.

    Medical Design Briefs

    Official Media Partner

    Medical Design Briefs (MDB) is the only publication for the medical OEM market dedicated to medical product design engineers and managers. We offer timely, accurate, quality content and editorial, and we report on engineering-related topics that are at the core of the latest medical technologies. From materials to manufacturing, we dive into the technical side of bringing medical devices to market. From biosensors to cybersecurity, we keep our fingers on the pulse of the hottest trends and topics that may augment or disrupt medical technology.

    Pharma network magazine

    Official Media Partner

    PHARMAnetwork is a company specialized in publishing for the pharmaceutical industry. PHARMAnetwork has developed publications for CMO, CDMO and professionals working in the life sciences. PHARMAnetwork designs specialized studies for pharmaceutical companies, contract service providers and investment firms. PHARMAnetwork magazine covers, every aspect of pharmaceutical value chain, the change and developments in the intersection between pharmaceutical industry and outsourcing industry. We perform interviews and write articles whose thematic strategies, organizations, mergers and acquisitions, regulatory, innovation in the pharmaceutical development and contract manufacturing. https://www.pharmanetwork.digital


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Horton Grand Hotel


    Horton Grand Hotel



    speaker image






    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.


    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.


    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.


    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title


    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event


    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group

    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out